Free tool streamlines ALS drug discovery with mass-spectrometry based model

Interested in finding a better way to develop drugs to treat amyotrophic lateral sclerosis (ALS), Northeastern researcher Jeffrey Agar and a team of scientists came up with a technique that improves the drug discovery workflow for an entire class of pharmaceuticals.